Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Level 6, West Wing, Oxford OX3 9DU, UK.
Joyce D. and Andrew J. Mandell Center for Comprehensive Multiple Sclerosis Care and Neuroscience Research, Mount Sinai Rehabilitation Hospital, Trinity Health Of New England, 490 Blue Hills Avenue, Hartford CT 06112, USA; Department of Rehabilitation Medicine, Frank H. Netter MD School of Medicine at Quinnipiac University, 370 Bassett Road, North Haven, CT 06473, USA; Department of Medical Sciences, Frank H. Netter MD School of Medicine at Quinnipiac University, 370 Bassett Road, North Haven, CT 06473, USA.
Mult Scler Relat Disord. 2022 Jul;63:103917. doi: 10.1016/j.msard.2022.103917. Epub 2022 Jun 1.
Dysfunction in upper limb (UL) function has been reported as an important indicator for disease progression in persons with multiple sclerosis (PwMS), thus a relevant outcome in clinical trials. However, standard assessment of UL function is limited to Nine-Hole Peg Test (NHPT) which assesses fine dexterity. This study aimed to deeply endophenotype UL involvement in PwMS and identify the most accurate set of measures needed to capture the complexity of UL dysfunction in the activities of daily living (ADL).
257 PwMS underwent an extensive UL assessment using standardized measures of grip strength and endurance, coordination, vibratory and tactile sensation, dexterity, capacity and functionality. Limitation in ADL was defined from an objective perspective using a timed test (Test d'Evaluation de la performance des Membres Supérieurs des Personnes Âgées: TEMPA) and from a subjective perspective using a questionnaire (Disabilities of the Arm, Shoulder and Hand: DASH). Disease severity subgroups were compared utilizing the Kruskal-Wallis test and frequencies determined the prevalence of abnormal UL for each measure. The Jonckheere-Terpstra test compared tested variables with disease severity. Then Receiver operating characteristic (ROC) curve analysis was used to test the accuracy of each tested variable in defining abnormality in the TEMPA and DASH. Cut-off scores were calculated using the Youden index. The predictive value of various tests over TEMPA and DASH were tested using a linear regression analysis.
UL dysfunction was highly prevalent in all the modalities tested, even in participants with no/mild disability. Box and Block Test (BBT), finger-nose test (FNT), and NHPT were independently selected with ROC analyses as the most accurate measures in detecting abnormalities in TEMPA and DASH. In multivariate regression models, BBT and FNT, and NHPT all contributed to predicting TEMPA (adj. R 0.795, P < 0.001), while only BBT and FNT predicted DASH.
UL dysfunction is highly prevalent in PwMS, even when global disability is mild. BBT and FNT are time-efficient and cost-effective measures that complement the NHPT for more precise monitoring of PwMS at all disease stages.
上肢(UL)功能障碍已被报道为多发性硬化症(PwMS)患者疾病进展的重要指标,因此也是临床试验中的相关结果。然而,UL 功能的标准评估仅限于九孔钉测试(NHPT),该测试评估精细灵巧度。本研究旨在深入研究 PwMS 的 UL 受累情况,并确定最准确的测量集,以捕捉日常生活活动(ADL)中 UL 功能障碍的复杂性。
257 名 PwMS 接受了广泛的 UL 评估,使用标准化的握力和耐力、协调性、振动和触觉、灵巧度、容量和功能的测量。使用计时测试(Test d'Evaluation de la performance des Membres Supérieurs des Personnes Âgées:TEMPA)从客观角度和使用问卷(手臂、肩膀和手残疾:DASH)从主观角度定义 ADL 受限。利用 Kruskal-Wallis 检验比较疾病严重程度亚组,利用频率确定每种测量的 UL 异常的患病率。Jonckheere-Terpstra 检验比较了测试变量与疾病严重程度。然后,使用接收者操作特征(ROC)曲线分析来测试每个测试变量在定义 TEMPA 和 DASH 异常方面的准确性。使用约登指数计算截断分数。使用线性回归分析测试各种测试对 TEMPA 和 DASH 的预测价值。
在所有测试的模式中,UL 功能障碍都非常普遍,即使在无/轻度残疾的参与者中也是如此。盒式和块式测试(BBT)、指鼻测试(FNT)和 NHPT 均通过 ROC 分析独立选择为检测 TEMPA 和 DASH 异常的最准确测量。在多元回归模型中,BBT 和 FNT 以及 NHPT 均有助于预测 TEMPA(调整后的 R 0.795,P<0.001),而只有 BBT 和 FNT 预测了 DASH。
即使整体残疾程度较轻,PwMS 中 UL 功能障碍也非常普遍。BBT 和 FNT 是高效且经济有效的措施,与 NHPT 一起可更精确地监测所有疾病阶段的 PwMS。